490 related articles for article (PubMed ID: 18584939)
21. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
Rouprêt M; Fromont G; Azzouzi AR; Catto JW; Vallancien G; Hamdy FC; Cussenot O
Urology; 2005 Jun; 65(6):1233-7. PubMed ID: 15922421
[TBL] [Abstract][Full Text] [Related]
22. Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis.
Milojevic B; Djokic M; Sipetic-Grujicic S; Milenkovic-Petronic D; Vuksanovic A; Bumbasirevic U; Vukovic I; Dragicevic D; Tulic C
BJU Int; 2012 Apr; 109(7):1037-42. PubMed ID: 21883837
[TBL] [Abstract][Full Text] [Related]
23. FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population.
Bodoor K; Ghabkari A; Jaradat Z; Alkhateeb A; Jaradat S; Al-Ghazo MA; Matalka I; Musleh H; Haddad Y
Cancer Epidemiol; 2010 Dec; 34(6):724-32. PubMed ID: 20542753
[TBL] [Abstract][Full Text] [Related]
24. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
[TBL] [Abstract][Full Text] [Related]
25. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
[TBL] [Abstract][Full Text] [Related]
26. [The expression of p53 and c-erb-2 in transitional cell carcinoma of the kidney pelvis and ureter and its relation to tumor progression and survival].
Fontana LO; García García F; Arcas Martínez Salas I; García Ligero J; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Canteras Jordana M
Arch Esp Urol; 2002 Sep; 55(7):792-6. PubMed ID: 12380307
[TBL] [Abstract][Full Text] [Related]
27. Incidence of fibroblast growth factor receptor 3 gene (FGFR3) A248C, S249C, G372C, and T375C mutations in bladder cancer.
Dodurga Y; Tataroglu C; Kesen Z; Satiroglu-Tufan NL
Genet Mol Res; 2011 Jan; 10(1):86-95. PubMed ID: 21264819
[TBL] [Abstract][Full Text] [Related]
28. [Urothelial cancer of the upper urinary tract].
Jurincic-Winkler C; Horlbeck R; Gasser A; Glenewinkel J; Klippel KF
Urologe A; 1993 Jul; 32(4):295-9. PubMed ID: 8372411
[TBL] [Abstract][Full Text] [Related]
29. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
[TBL] [Abstract][Full Text] [Related]
30. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
[TBL] [Abstract][Full Text] [Related]
31. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
Wu CF; Chang PL; Chen CS; Chuang CK; Weng HH; Pang ST
J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
[TBL] [Abstract][Full Text] [Related]
32. Mutations of fibroblast growth factor receptor 3 gene (FGFR3) in transitional cell carcinoma of urinary bladder in Thai patients [Revision-2a].
Jantip J; Tanthanuch M; Kanngurn S; Karnchanawanichkul W; Pripatnanont C; Sangkhathat S; Thongsuksai P
J Med Assoc Thai; 2013 Aug; 96(8):976-83. PubMed ID: 23991606
[TBL] [Abstract][Full Text] [Related]
33. Frequent FGFR3 mutations in urothelial papilloma.
van Rhijn BW; Montironi R; Zwarthoff EC; Jöbsis AC; van der Kwast TH
J Pathol; 2002 Oct; 198(2):245-51. PubMed ID: 12237885
[TBL] [Abstract][Full Text] [Related]
34. The FGFR3 mutation is related to favorable pT1 bladder cancer.
van Rhijn BW; van der Kwast TH; Liu L; Fleshner NE; Bostrom PJ; Vis AN; Alkhateeb SS; Bangma CH; Jewett MA; Zwarthoff EC; Zlotta AR; Bapat B
J Urol; 2012 Jan; 187(1):310-4. PubMed ID: 22099989
[TBL] [Abstract][Full Text] [Related]
35. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer.
Zuiverloon TC; van der Aa MN; van der Kwast TH; Steyerberg EW; Lingsma HF; Bangma CH; Zwarthoff EC
Clin Cancer Res; 2010 Jun; 16(11):3011-8. PubMed ID: 20404005
[TBL] [Abstract][Full Text] [Related]
37. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
[TBL] [Abstract][Full Text] [Related]
38. Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker.
Pignot G; Bieche I; Vacher S; Güet C; Vieillefond A; Debré B; Lidereau R; Amsellem-Ouazana D
Eur Urol; 2009 Oct; 56(4):678-88. PubMed ID: 18513850
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.
Gómez-Román JJ; Saenz P; Molina M; Cuevas González J; Escuredo K; Santa Cruz S; Junquera C; Simón L; Martínez A; Gutiérrez Baños JL; López-Brea M; Esparza C; Val-Bernal JF
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):459-65. PubMed ID: 15701828
[TBL] [Abstract][Full Text] [Related]
40. FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapy.
Sung JY; Sun JM; Chang Jeong B; Il Seo S; Soo Jeon S; Moo Lee H; Yong Choi H; Young Kang S; Choi YL; Young Kwon G
Urol Oncol; 2014 Jan; 32(1):49.e23-31. PubMed ID: 24360661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
